Nature Microbiology Клеточная биология
Turning a Staphylococcus aureus virulence factor into an antibacterial therapy
Аннотация
We describe FibriLysins, dual-action proteins that dismantle the fibrin structures encapsulating Staphylococcus aureus multicellular communities and kill the bacteria within. In a mouse model of device-associated infection, FibriLysins demonstrate higher antibacterial efficacy compared with the standard-of-care antibiotic vancomycin. These findings highlight the potential of FibriLysins to treat recalcitrant S. aureus infections.